2-32947453-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_206943.4(LTBP1):c.129G>T(p.Leu43Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000762 in 1,442,914 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206943.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP1 | NM_206943.4 | c.129G>T | p.Leu43Phe | missense_variant | 1/34 | ENST00000404816.7 | NP_996826.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP1 | ENST00000404816.7 | c.129G>T | p.Leu43Phe | missense_variant | 1/34 | 5 | NM_206943.4 | ENSP00000386043 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151592Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000143 AC: 1AN: 69956Hom.: 0 AF XY: 0.0000246 AC XY: 1AN XY: 40586
GnomAD4 exome AF: 0.0000805 AC: 104AN: 1291322Hom.: 1 Cov.: 34 AF XY: 0.0000707 AC XY: 45AN XY: 636110
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151592Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74024
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The c.129G>T (p.L43F) alteration is located in exon 1 (coding exon 1) of the LTBP1 gene. This alteration results from a G to T substitution at nucleotide position 129, causing the leucine (L) at amino acid position 43 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at